Imipenem–cilastatin–funobactam versus imipenem–cilastatin–relebactam in patients with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia: a phase 3, double-blind, non-inferiority randomised trial

The Lancet Infectious Diseases · Elsevier

Аннотация

Publication date: Available online 4 November 2026 Source: The Lancet Infectious Diseases Author(s): Kang Chang, Yimin Wang, Chengmou Wang, Zhengang Tang, Jiangliu Yin, Jiankang Zhao, Yeming Wang, Tao Mei, Aimin Li, Hui Li, Qiuhua Jiang, Peifu Wang, Feng Ye, Lianshu Ding, Zengqiang Liu, Feng Yin, Xueliang Mo, Hongtao Qu, Ying Xia, Jiyue Wang

Читать у издателя →

Похожие статьи